{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:25:53Z","timestamp":1781796353341,"version":"3.54.5"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T00:00:00Z","timestamp":1534464000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DK04056 1"],"award-info":[{"award-number":["P30 DK04056 1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004088","name":"Kowa Life Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004088","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ebiom.2018.08.039","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T22:26:37Z","timestamp":1535667997000},"page":"58-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Assessing statin effects on cardiovascular pathways in HIV using a novel proteomics approach: Analysis of data from INTREPID, a randomized controlled trial"],"prefix":"10.1016","volume":"35","author":[{"given":"Mabel","family":"Toribio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen V.","family":"Fitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markella V.","family":"Zanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"de Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"Sponseller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Grundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie A.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Aberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven K.","family":"Grinspoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ebiom.2018.08.039_bb0005","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1210\/jc.2006-2190","article-title":"Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease","volume":"92","author":"Triant","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.ebiom.2018.08.039_bb0010","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","article-title":"HIV infection and the risk of acute myocardial infarction","volume":"173","author":"Freiberg","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.ebiom.2018.08.039_bb0015","first-page":"35","article-title":"Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus","volume":"11","author":"Beltran","year":"2015","journal-title":"Vasc. Health Risk Manag."},{"issue":"14","key":"10.1016\/j.ebiom.2018.08.039_bb0020","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1097\/QAD.0000000000001167","article-title":"Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection","volume":"30","author":"Longenecker","year":"2016","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.ebiom.2018.08.039_bb0025","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/S2352-3018(14)00032-0","article-title":"Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: A randomised, double-blind, placebo-controlled trial","volume":"2","author":"Lo","year":"2015","journal-title":"Lancet HIV"},{"issue":"7","key":"10.1016\/j.ebiom.2018.08.039_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(17)30075-9","article-title":"Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial","volume":"4","author":"Aberg","year":"2017","journal-title":"Lancet HIV"},{"issue":"6","key":"10.1016\/j.ebiom.2018.08.039_bb0035","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/QAD.0000000000001427","article-title":"Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in HIV","volume":"31","author":"Toribio","year":"2017","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.ebiom.2018.08.039_bb0040","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/QAD.0000000000000158","article-title":"Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection","volume":"28","author":"Longenecker","year":"2014","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.ebiom.2018.08.039_bb0045","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/infdis\/jiq118","article-title":"Plasma levels of soluble CD14 independently predict mortality in HIV infection","volume":"203","author":"Sandler","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.ebiom.2018.08.039_bb0050","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/QAD.0000000000001762","article-title":"Novel mediators of statin effects on plaque in HIV: A proteomics approach","volume":"32","author":"Defilippi","year":"2018","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.ebiom.2018.08.039_bb0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.atherosclerosis.2015.07.023","article-title":"Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosis","volume":"242","author":"Lind","year":"2015","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.ebiom.2018.08.039_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.ebiom.2018.08.039_bb0065","first-page":"289","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. Royal Stat. Society 1995"},{"issue":"Suppl. 1","key":"10.1016\/j.ebiom.2018.08.039_bb0070","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0140-6736(15)60336-1","article-title":"Pleiotropic effects of statins in hypercholesterolaemia: a prospective observational study using a lipoproteomic based approach","volume":"385","author":"Bhandari","year":"2015","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ebiom.2018.08.039_bb0075","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1194\/jlr.M073882","article-title":"Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: Effects of rosuvastatin","volume":"58","author":"Thongtang","year":"2017","journal-title":"J. Lipid Res."},{"issue":"7","key":"10.1016\/j.ebiom.2018.08.039_bb0080","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/pmic.200700583","article-title":"Atorvastatin modifies the protein profile of circulating human monocytes after an acute coronary syndrome","volume":"9","author":"Barderas","year":"2009","journal-title":"Proteomics"},{"issue":"12","key":"10.1016\/j.ebiom.2018.08.039_bb0085","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1074\/mcp.M115.054031","article-title":"Rosuvastatin alters the proteome of high density lipoproteins: Generation of alpha-1-antitrypsin enriched particles with anti-inflammatory properties","volume":"14","author":"Gordon","year":"2015","journal-title":"Mol. Cell. Proteomics"},{"issue":"10","key":"10.1016\/j.ebiom.2018.08.039_bb0090","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s40262-013-0075-4","article-title":"Drug-drug interactions between HMG-CoA reductase inhibitors (statins) and antiviral protease inhibitors","volume":"52","author":"Chauvin","year":"2013","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.ebiom.2018.08.039_bb0095","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.atherosclerosis.2006.08.023","article-title":"Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease","volume":"194","author":"Sugiyama","year":"2007","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.ebiom.2018.08.039_bb0100","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1507\/endocrj.K06-198","article-title":"Preferable effect of pravastatin compared to atorvastatin on beta cell function in Japanese early-state type 2 diabetes with hypercholesterolemia","volume":"54","author":"Mita","year":"2007","journal-title":"Endocr. J."},{"issue":"3","key":"10.1016\/j.ebiom.2018.08.039_bb0105","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/jdi.12032","article-title":"Comparison of effects of pitavastatin and atorvastatin on glucose metabolism in type 2 diabetic patients with hypercholesterolemia","volume":"4","author":"Mita","year":"2013","journal-title":"J. Diabet. Investig."},{"issue":"1","key":"10.1016\/j.ebiom.2018.08.039_bb0110","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1186\/s13063-017-2229-4","article-title":"Long-term Effects of high-doSe pitavaStatin on diabetogenicity in comparison with atorvastatin in patients with metabolic syndrome (LESS-DM): study protocol for a randomized controlled trial","volume":"18","author":"Park","year":"2017","journal-title":"Trials"},{"issue":"2","key":"10.1016\/j.ebiom.2018.08.039_bb0115","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/01.ATV.14.2.223","article-title":"Tissue-factor pathway inhibitor and lipoproteins. Evidence for association with and regulation by LDL in human plasma","volume":"14","author":"Hansen","year":"1994","journal-title":"Arterioscler. Thromb."},{"issue":"3","key":"10.1016\/j.ebiom.2018.08.039_bb0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.blre.2013.03.001","article-title":"The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis","volume":"27","author":"Winckers","year":"2013","journal-title":"Blood Rev."},{"issue":"11","key":"10.1016\/j.ebiom.2018.08.039_bb0125","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1161\/01.ATV.15.11.2055","article-title":"Thrombin induces the redistribution and acute release of tissue factor pathway inhibitor from specific granules within human endothelial cells in culture","volume":"15","author":"Lupu","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9054","key":"10.1016\/j.ebiom.2018.08.039_bb0130","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(96)11189-2","article-title":"Tissue-factor antigen and activity in human coronary atherosclerotic plaques","volume":"349","author":"Ardissino","year":"1997","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ebiom.2018.08.039_bb0135","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1055\/s-0038-1651613","article-title":"Distribution of tissue factor pathway inhibitor in normal and malignant human tissues","volume":"69","author":"Werling","year":"1993","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.ebiom.2018.08.039_bb0140","first-page":"959","article-title":"Structure and biology of tissue factor pathway inhibitor","volume":"86","author":"Bajaj","year":"2001","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.ebiom.2018.08.039_bb0145","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.atherosclerosis.2009.04.024","article-title":"Tissue factor pathway inhibitor, vascular risk factors and subclinical atherosclerosis: the multi-ethnic study of atherosclerosis","volume":"207","author":"Mitchell","year":"2009","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.ebiom.2018.08.039_bb0150","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1182\/blood-2009-03-210179","article-title":"Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation","volume":"115","author":"Funderburg","year":"2010","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.ebiom.2018.08.039_bb0155","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1182\/blood-2012-05-433946","article-title":"Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome","volume":"120","author":"Funderburg","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ebiom.2018.08.039_bb0160","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0049-3848(97)00029-7","article-title":"Tissue factor pathway inhibitor in complex with low density lipoprotein isolated from human plasma does not possess anticoagulant function in tissue factor-induced coagulation in vitro","volume":"85","author":"Hansen","year":"1997","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.ebiom.2018.08.039_bb0165","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.2012.6698","article-title":"Arterial inflammation in patients with HIV","volume":"308","author":"Subramanian","year":"2012","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ebiom.2018.08.039_bb0170","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1001\/jamacardio.2016.0846","article-title":"Effects of antiretroviral therapy on immune function and arterial inflammation in treatment-naive patients with human immunodeficiency virus infection","volume":"1","author":"Zanni","year":"2016","journal-title":"JAMA Cardiol."},{"issue":"8","key":"10.1016\/j.ebiom.2018.08.039_bb0175","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/infdis\/jix095","article-title":"Application of a novel CD206+ macrophage-specific arterial imaging strategy in HIV","volume":"215","author":"Zanni","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"9725","key":"10.1016\/j.ebiom.2018.08.039_bb0180","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(10)60319-4","article-title":"Lipoprotein-associated phospholipase a(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies","volume":"375","author":"Thompson","year":"2010","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ebiom.2018.08.039_bb0185","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/hiv.12143","article-title":"Lipoprotein-associated phospholipase a and cardiovascular disease risk in HIV infection","volume":"15","author":"Ross Eckard","year":"2014","journal-title":"HIV Med."},{"issue":"6","key":"10.1016\/j.ebiom.2018.08.039_bb0190","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/cid\/cit815","article-title":"Lipoprotein-associated phospholipase A2, a novel cardiovascular inflammatory marker, in HIV-infected patients","volume":"58","author":"Mangili","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"22","key":"10.1016\/j.ebiom.2018.08.039_bb0195","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1161\/01.CIR.0000131660.51520.9A","article-title":"Bidirectional relation between inflammation and coagulation","volume":"109","author":"Levi","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ebiom.2018.08.039_bb0200","first-page":"226","article-title":"Review: the role of paraoxonase in cardiovascular diseases","volume":"45","author":"Kowalska","year":"2015","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"1","key":"10.1016\/j.ebiom.2018.08.039_bb0205","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1194\/jlr.P018457","article-title":"Serum paraoxonase-3 concentration in HIV-infected patients. Evidence for a protective role against oxidation","volume":"53","author":"Aragones","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ebiom.2018.08.039_bb0210","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8910396","article-title":"Oxidative stress during HIV infection: Mechanisms and consequences","volume":"2016","author":"Ivanov","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.ebiom.2018.08.039_bb0215","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2174\/157340310793566181","article-title":"Lipid rafts and redox regulation of cellular signaling in cholesterol induced atherosclerosis","volume":"6","author":"Catalgol","year":"2010","journal-title":"Curr. Cardiol. Rev."},{"issue":"2","key":"10.1016\/j.ebiom.2018.08.039_bb0220","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.atherosclerosis.2011.10.016","article-title":"Lipid rafts: a signalling platform linking lipoprotein metabolism to atherogenesis","volume":"221","author":"Lemaire-Ewing","year":"2012","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.ebiom.2018.08.039_bb0225","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/01.HYP.0000196727.53300.62","article-title":"Lipid raft clustering and redox signaling platform formation in coronary arterial endothelial cells","volume":"47","author":"Zhang","year":"2006","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.ebiom.2018.08.039_bb0230","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1006\/abbi.1996.0030","article-title":"Inhibitors of cholesterol biosynthesis increase hepatic low-density lipoprotein receptor protein degradation","volume":"325","author":"Ness","year":"1996","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ebiom.2018.08.039_bb0235","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3035184","article-title":"Insulin-like growth factor (IGF) binding protein-2, independently of IGF-1, induces GLUT-4 translocation and glucose uptake in 3T3-L1 adipocytes","volume":"2017","author":"Assefa","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"9","key":"10.1016\/j.ebiom.2018.08.039_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044454","article-title":"Inflammation, coagulation and cardiovascular disease in HIV-infected individuals","volume":"7","author":"Duprez","year":"2012","journal-title":"PLoS ONE"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418303359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396418303359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:47:18Z","timestamp":1762454838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396418303359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":48,"alternative-id":["S2352396418303359"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.08.039","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing statin effects on cardiovascular pathways in HIV using a novel proteomics approach: Analysis of data from INTREPID, a randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2018.08.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}